ANDA 88195, held by Usl Pharma. Hydroflumethiazide; Reserpine.
As of Nov 15, 2026, ANDA 88195 (Hydroflumethiazide And Reserpine), held by Usl Pharma, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydroflumethiazide And Reserpine50MG;0.125MG ยท tablet;oral | Hydroflumethiazide; Reserpine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
